Ebixa 20 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

ebixa 20 mg

orifarm as - memantinhydroklorid - tablett, filmdrasjert - 20 mg

MicardisPlus 80 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

micardisplus 80 mg / 12.5 mg

farmagon - telmisartan / hydroklortiazid - tablett - 80 mg / 12.5 mg

Fampyra ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multippel sklerose - andre nervesystemet narkotika - fampyra angis for forbedring av gåing i voksen pasienter med multippel sklerose innen funksjonshemming (utvidet funksjonshemming status skala 4-7).

Fampyra 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

fampyra 10 mg

orifarm as - fampridin - depottablett - 10 mg

Fampridine Accord ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multippel sklerose - andre nervesystemet narkotika - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Fampridine Sandoz 10 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

fampridine sandoz 10 mg

sandoz a/s - fampridin - depottablett - 10 mg

Effentora ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

effentora

teva b.v. - fentanyl - pain; cancer - analgetika - effentora er indisert for behandling av gjennombrudd smerte (btp) i voksne med kreft som er allerede mottar vedlikehold opioid terapi for kronisk kreft smerter. btp er en forbigående forverring av smerte som oppstår på bakgrunn av kontrollert vedvarende smerte. pasienter som mottar vedlikehold opioid behandling er de som tar minst 60 mg av oral morfin daglig, minst 25 mikrogram av transdermal fentanyl per time, minst 30 mg av oxycodone daglig, minst 8 mg av p-hydromorphone daglig eller en equianalgesic dose av et annet opioid-for en uke eller lenger.

Hemangiol ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

hemangiol

pierre fabre medicament - propranolol hydroklorid - hemangiom - betablokkende midler - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

Atacand Plus 16 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

atacand plus 16 mg / 12.5 mg

orifarm as - kandesartancileksetil / hydroklortiazid - tablett - 16 mg / 12.5 mg

Kandesartan-Hydroklortiazid Farmagon 16 mg / 12.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

kandesartan-hydroklortiazid farmagon 16 mg / 12.5 mg

farmagon - kandesartancileksetil / hydroklortiazid - tablett - 16 mg / 12.5 mg